A template image of dopamine D2 receptor density was derived from 6 PET scans in healthy volunteers using the high affinity D2/D3 antagonist ligand [18F]-Fallypride. Brain mRNA expression values for DRD2 gene (coding for D2R) were extracted from the ABA dataset by using the MENGA toolbox. CBF contrast images and the [18F]Fallypride BPND template were segmented into 83 ROIs by using the Desikan-Killiany Atlas. The regional changes in CBF against placebo (∆CBF) were compared with regional BPND values and gene expression maps using multivariate correlations. Results: For all antipsychotics, CBF changes in each ROI were directly proportional to [18F]Fallypride non displaceable binding potential (BPND) values (OLA R2= 0.24, HAL R2= 0.61, lowRIS R2= 0.54, highRIS R2= 0.52, all p<0.001) and DRD2 mRNA expression levels (OLA R2= 0.04, HAL R2= 0.15, lowRIS R2= 0.19, highRIS R2= 0.20, all chance likelihood <2%). Discussion: In the present study, we were able to show that the CBF increase induced by antipsychotic is directly proportional to D2R concentration in the brain, as indexed by PET BPND maps and mRNA expression levels. Interestingly, the association strength between ∆CBF and brain receptor distribution profiles mirrored differential D2R affinity between the tested drugs. Overall, these results indicate that CBF increases after administration of a single dose of antipsychotics actually reflect known pharmacodynamics profile of these compounds. In addition, these results further reinforce previous evidence suggesting the role of D2R blockade as a mechanism behind increased CBF induced by antipsychotics. Finally, CBF is ultimately a functional marker and this work is important in bridging the considerable gap between the pharmacokinetic and pharmacodynamic effects of compounds with unclear brain functional effects like antipsychotics. Background: Studies using the event sampling method (ESM), a structured diary technique measuring subjective experiences and emotional fluctuations in daily life, have consistently shown that individuals reporting psychotic experiences display a heightened emotional reactivity to minor stressors-a neuropsychological mechanism that likely contributes to the development and perpetuation of psychotic experiences. Except a few undersized non-replicated candidate-gene studies showing an association between genetic variations and elevated momentary stress reactivity, genetic underpinnings of emotion reactivity to momentary stressors have not been investigated. Therefore, by leveraging a large general population twin dataset of ESM, we aimed to investigate-for the first time-whether the polygenic risk score (PRS) for schizophrenia moderates stress reactivity (psychotic experiences (PE) and negative affect (NA) in response to momentary stress). Methods: Data were derived from a general population adolescent and young adult twin sample. The total sample included 638 participants (Monozygotic = 202, Dizygotic = 436). ESM variables were randomly measured at 10 times/day over 6 consecutive days. For the main analyses, we assessed ESM information on PE (suspiciousness, loss of control, racing thoughts, pervasive thoughts, difficulties to express thoughts), NA (feeling lonely, anxious, listless, down, guilty), and event-related stress (pleasantness of the most important event since last entry); and for additional explorative analyses we assessed social stress (participants were asked with whom they are (e.g. nobody or family) and to rate the pleasantness of the social situation). PRS were trained on the results from the Psychiatric Genetics Consortium-2 SZ. Multilevel regression analyses, taking into account of multiple observations nested within twins who were clustered within family, were used to analyze the moderating effects of PRS (at p-value < 0.05) on the relationship between momentary stress and NA or PE. All analyses were adjusted for age, sex and 2 principle components. Results: There were significant main effects of momentary stress (event stress: b = 0.065, p < 0.001, 95% CI = 0.048, 0.082; social stress: b = 0.128; p < 0.001; 95% CI = 0.111, 0.145) on PE. However, neither the main effects of PRS on PE nor the interaction between PRS and momentary stress on PE were significant. The analysis with NA as dependent variable indicated main effects of momentary stress (event stress: b = 0.096; p <0.001; 95% CI = 0.081, 0.111; social stress: b = 0.180; p < 0.001; 95% CI = 0.164, 0.197), but no main effect of PRS. There was a significant negative interaction between PRS and both event-related stress (b = -0.016; p = 0.024; 95% CI = -0.031, -0.002) and social stress (b = -0.017; p = 0.024; 95% CI = -0.031, -0.002) on NA. Discussion: This is the first study investigating the influence of molecular genetic risk for schizophrenia on momentary stress reactivity, measured using an ecologically valid diary method. These results suggest that PRS for schizophrenia does not have an effect on psychotic stress responses, while increased genetic risk for schizophrenia showed a buffering effect on the association between momentary stress and NA. It is possible that individuals with high PRS for schizophrenia might have emotional response deficits, a characteristic of the clinical phenotype. Alternatively, these individuals might have been less accurate in self-evaluating momentary stress, attributing high values to stressors that genuinely do not have an impact on their emotion regulation. Future studies, investigating both clinical and general populations, are required to elucidate the impact of PRS on stress reactivity. Background: The Clinical Record Interactive Search (CRIS) database provides anonymised data from the full electronic health records of all patients at the South London and Maudsley NHS Foundation Trust, a large provider of secondary mental health care. We have previously shown how the large volumes of available CRIS data pertaining to outcomes can be mined and integrated with patient data collected by historical research interview. The applications of this futuristic translational research model are yet to be fully explored. The aim of this study is to determine whether transcriptomic
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